Swollen Knee Treatment Market: Global Industry Analysis and Forecast (2023-2029)

Global Swollen Knee Treatment Market size was valued at US$ 2 Bn. in 2022 and the total revenue is expected to grow at a CAGR of 4.5% through 2023 to 2029, reaching nearly US$ 2.73 Bn.
Swollen Knee Treatment Market Overview:
Senior citizens often experience swollen knees. Fluid accumulates around the knee joint causing it to swell. Trauma or accidents that result in injuries like torn ligaments, cartilage tears, and broken bones, as well as underlying causes like rheumatoid arthritis, gout, and tumours, can all lead to these injuries. Inflammation of the knees can cause acute joint discomfort, which may require emergency medication.To know about the Research Methodology:- Request Free Sample Report
Market Dynamics:
The pharmaceutical and biotech industries, in collaboration with governments around the world, are developing vaccines and planning pharmaceutical supply chains to combat the COVID-19 outbreak. The Research and Development pipeline contains approximately 115 vaccine candidates and 155 compounds. COVID-19 treatments such as hydroxychloroquine have also seen an increase in demand. Many wealthy countries are running out of these drugs due to the huge demand for COVID-19 management drugs. During the forecast period, the pharmaceutical and biotechnology industries are expected to grow significantly due to the demand for COVID-19 vaccines and treatment medications. Thus, the global swollen knee treatment market is expected to be significantly impacted.

Swollen knee treatment market is expected to grow as the global elderly population grows, resulting in an increase in incidence of ageing syndromes such as obesity, arthritis, diabetes, and sports-related injuries. In developed markets such as North America and Europe, rising awareness regarding new age technology developments such as minimal invasive therapies is expected to boost swollen knee treatment market growth.

The global financial crisis, along with a total transformation in healthcare infrastructure to combat COVID-19 and its impacts, has resulted in product delays and clinical trial cancellations. This is expected to inevitably slow the growth of the knee replacement market. Growing awareness of the side effects and problems connected with surgical replacements, as well as a shift toward non-surgical healthcare mechanisms such as therapeutic procedures and prophylactic procedures, are expected to restrains the market growth for knee replacement treatment mechanisms.
Swollen Knee Treatment Market Segment Analysis:
Based on the Type, the market is segmented into Medications, Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine, and Surgery. Medications segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. The advantages of medications are the beneficial affects you obtain from them, such as pain relief, blood sugar control, blood pressure reduction, or infection cure.

Based on the Medications, the market is segmented into Opioids, Corticosteroids, and Others. Corticosteroids medications segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. Corticosteroid injections can help with OA pain flare-ups and swelling caused by fluid build-up in the knee. These injections help to alleviate discomfort by lowering joint inflammation.

In the Netherlands, the number of corticosteroid users for local use in the mouth was estimated to be 6,407 in 2022. The use of prescribed corticosteroids increased dramatically year after year over the years studied.

Opioids medications segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. Medications such as opiates are commonly used to relieve pain since they contain substances that relax the body. In some cases, opioid prescriptions are used to treat coughing and diarrhoea as well as moderate to severe pain.

Based on the Knee Replacement Type, the market is segmented into Total Knee Replacement, Unicompartmental Knee Replacement, and Others. Total knee replacement segment is expected to hold the largest market share of xx% by 2029. Total knee replacement (TKR) for knee osteoarthritis improves quality of life the most in patients with more severe functional impairment, while it improves quality of life just somewhat in those with less severe impairment. In the United States, 12 percent of adults have osteoarthritis of the knee, which is a major source of disability. In the United States, more than 640,000 TKR operations are performed each year. Due to the inclusion of patients with less impaired physical function, the number of TKR procedures has grown.
Regional Insights:
North America region is expected to dominate the Swollen Knee Treatment market during the forecast period 2023-2029. North America region is expected to hold the largest market share of xx% by 2029. This is due to the region's growing senior population, solid healthcare infrastructure, rising public awareness, and efficient buying parity to spend on innovative pharmaceuticals.

The Food and Drug Administration (FDA) recently approved a novel treatment called "cooled radio frequency ablation" for use in the United States. Radio waves are used to target nerves involved for delivering pain signals to the brain in this treatment. As far as knee regeneration goes, the treatment has shown pain decrease for nearly a year. Kitov Pharma Ltd. teamed up with Coeptis Pharmaceuticals in October 2019 to operate the Consensi channel in the United States.

The objective of the report is to present a comprehensive analysis of the Global Swollen Knee Treatment Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Swollen Knee Treatment Market dynamic, structure by analyzing the market segments and project the Global Swollen Knee Treatment Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Swollen Knee Treatment Market make the report investor’s guide.
Swollen Knee Treatment Market Scope: Inquire before buying



Swollen Knee Treatment Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 2 Bn.


Forecast Period 2023 to 2029 CAGR:
4.5%
Market Size in 2029:
US $ 2.73 Bn.


 Segments Covered:
by Type
Medications
Patient-controlled Analgesia Pumps
Nerve Blocks
Liposomal Bupivacaine
Surgery


by Medications
Opioids
Corticosteroids
Others


by Surgery
Arthrocentesis
Arthroscopy
Knee Replacement


by Knee Replacement Type
Total Knee Replacement
Unicompartmental Knee Replacement
Others


by End-User
Hospitals
Designated Clinics
Ambulatory Surgical Centers
Others



Swollen Knee Treatment Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina and Rest of South America)
Swollen Knee Treatment Market Key Players are:
1. Stryker Corporation
2. Zimmer Holdings
3. Smith & Nephew Plc.
4. DePuy Companies Inc.
5. Wright Medical Group Inc.
6. Biomet Inc.
7. Exactech
8. B. Braun Melsungen AG
9. Pfizer Pharmaceuticals Inc.
10.Merck & Co.
11.Fresenius Kabi
12.AngioDynamics
13.C.R.Bard
14.Teleflex
15.Smiths Medical
Frequently Asked Questions:
1] Which region is expected to hold the highest share in the Swollen Knee Treatment Market?
Ans. North America is expected to hold the highest share in the Swollen Knee Treatment Market.

2] Who are the top key players in the Swollen Knee Treatment Market?
Ans. Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., and Biomet Inc. are the top key players in the Swollen Knee Treatment Market.

3] Which segment holds the largest market share in the Swollen Knee Treatment market by 2029?
Ans. Total knee replacement segment hold the largest market share in the Swollen Knee Treatment market by 2029.

4] What is the market size of the Swollen Knee Treatment market by 2029?
Ans. The market size of the Swollen Knee Treatment market is expected to reach US $ 2.73 Bn. by 2029.

5] What was the market size of the Swollen Knee Treatment market in 2022?
Ans. The market size of the Swollen Knee Treatment market was worth US $ 2 Bn. in 2022.